• Welcome to Renmin Hospital of Wuhan University
  • 网站首页 中文版 English Francaise
    • 院内导航
    唐其柱 心内
    武汉大学党委常委，副校长、医学部部长，二级教授，一级主任医师，博士生导师，代谢与相关慢病湖北省重点实验室主任
    A+ A-
    导师介绍

    姓名 唐其柱
    出生年月 1963年6月
    单位 武汉大学人民医院心血管内科
    所属学科 临床医学-内科学
    职务、职称及头衔 武汉大学党委常委，副校长、医学部部长，二级教授，一级主任医师，博士生导师，代谢与相关慢病湖北省重点实验室主任
    E-mail qztang@whu.edu.cn
    联系方式 13507192218
    研究方向 1.心肌重构与心血管病防治
    2.心力衰竭与心肌病的发生机制与防治
    个人简介 长期致力于心血管疾病的防治及科研工作，先后主持国家重点研发计划、国家自然科学基金区域创新发展联合基金项目、国家自然科学基金重点项目和面上项目等10余项。在国内外专业期刊发表论文300余篇(其中SCI收入120余篇)；主编专著7部、参编专著22部，主持完成湖北省科技进步一等奖2项，已获授权发明专利2项、实用新型专利1项、软著1项。已培养硕士研究生52人，博士研究生37人。在2012-2022爱思唯尔“中国高被引学者”中心血管排名第9。
    学术任职与荣誉 教育部科学技术委员会委员
    中国医师协会常务理事
    中国生物医学工程学会常务理事
    中央“万人计划”百千万工程领军人才(2016年)
    卫生部“有突出贡献中青年专家”（2012年）
    中国医师奖获得者（2018年）
    全国五一劳动奖章获得者（2011年）
    湖北省五一劳动奖章获得者（2012年）
    湖北省首届医学领军人才（2013年）
    武汉大学珞珈杰出学者（2009年）
    国务院政府特殊津贴（2004年）
    教育履历 1981.9-1986.6湖北医学院医学系本科学习，获医学学士学位
    1988.9-1991.6湖北医学院心血管病学硕士研究生，获医学硕士学位
    2000.9-2003.6武汉大学心血管病学博士研究生，获医学博士学位
    2004.9-2007.6北京大学中国经济研究中心EMBA，获高级工商管理硕士学位
    工作履历 1986.7-1988.8湖北医科大学附属第一医院(湖北省人民医院)内科医师
    1991.7-1993.10湖北医科大学附属第一医院(湖北省人民医院)心内科医师
    1993.10-1995.9湖北医科大学附属第一医院(湖北省人民医院)心内科主治医师
    1995.10-1999.3湖北医科大学附属第一医院(湖北省人民医院)心内科副主任医师、副教授
    1999.3-2000.8湖北医科大学附属第一医院(湖北省人民医院)心内科主任医师、副教授
    2000.8-2001.1武汉大学人民医院(湖北省人民医院)心内科主任医师、副教授
    2001.1-至今武汉大学人民医院(湖北省人民医院)心内科主任医师、教授
    1997.8-2000.8湖北医科大学附属第一医院(湖北省人民医院)党委常委、副院长
    2000.8-2005.4武汉大学人民医院(湖北省人民医院)党委常委、副院长
    2005.4-2014.6武汉大学人民医院(湖北省人民医院)党委书记、副院长
    2014.6-2016.9武汉大学人民医院(湖北省人民医院)院长、党委书记
    2016.9-2019.11武汉大学人民医院(湖北省人民医院)院长
    2019.1-至今武汉大学党委常委、副校长兼医学部部长
    成果获奖 1、2013年，湖北省科技进步一等奖，第一完成人（心肌重构的发病基础与临床防治）
    2、2019年，湖北省科技进步一等奖，第一完成人（心力衰竭的结构重构与防治）
    3、2001年，国家科学技术进步二等奖，第四完成人（房室结折返性心动过速的发病基础及射频消融）
    4、2011年，国家科学技术进步二等奖，第三完成人（心律失常的结构和神经重构的基础研究与临床防治）
    5、2005年，国家科学技术进步二等奖，第九完成人（心房颤动的基础与临床研究）
    6、2016年，湖北省科技进步一等奖，第二完成人（心血管病模式动物的构建及其应用）
    代表性论著 (1) Zhang X, Hu C, Ma ZG, Hu M, Yuan XP, Yuan YP, Wang SS, Kong CY, Teng T,Tang QZ. Tisp40 prevents cardiac ischemia/reperfusion injury through the hexosamine biosynthetic pathway in male mice. Nat Commun. 2023 Jun 8;14(1):3383. doi: 10.1038/s41467-023-39159-0. PMID: 37291168; PMCID: PMC10250363. 2023-06-08中科院医学1区top影响因子：16.6

    (2) Xie S, Xu SC, Deng W,Tang Q. Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications. Signal Transduct Target Ther. 2023 Mar 14;8(1):114. doi: 10.1038/s41392-023-01378-8. PMID: 36918543; PMCID: PMC10015017. 2023-03-14中科院医学1区top影响因子：39.3

    (3) Xie S, Xing Y, Shi W, Zhang M, Chen M, Fang W, Liu S, Zhang T, Zeng X, Chen S, Wang S, Deng W,Tang Q. Cardiac fibroblast heat shock protein 47 aggravates cardiac fibrosis post myocardial ischemia-reperfusion injury by encouraging ubiquitin specific peptidase 10 dependent Smad4 deubiquitination. Acta Pharm Sin B. 2022 Nov;12(11):4138-4153. doi: 10.1016/j.apsb.2022.07.022. PMID: 36386478; PMCID: PMC9643299. 2022-08-05中科院医学1区top影响因子：14.5

    (4) Hu T, Wu Q, Yao Q, Jiang K, Yu J,Tang Q. Short-chain fatty acid metabolism and multiple effects on cardiovascular diseases. Ageing Res Rev. 2022 Nov;81:101706. doi: 10.1016/j.arr.2022.101706. Epub 2022 Aug 4. PMID: 35932976. 2022-08-04中科院生物1区top IF=13.1

    (5) Xie S, Chen M#, Fang W#, Liu S, Wu Q, Liu C, Xing Y, Shi W, Xu M, Zhang M, Chen S, Zeng X, Wang S, Deng W,Tang Q. Diminished arachidonate 5-lipoxygenase perturbs phase separation and transcriptional response of Runx2 to reverse pathological ventricular remodeling. EBioMedicine. 2022 Dec;86:104359. doi: 10.1016/j.ebiom.2022.104359. PMID: 36395739; PMCID: PMC9672960. 2022-11-14中科院生物1区top影响因子：11.1

    (6) Hu T, Wu Q, Yao Q, Yu J, Jiang K, Wan Y,Tang Q. PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy. Metabolism. 2023 Jul 9:155658. doi: 10.1016/j.metabol.2023.155658. Epub ahead of print. PMID: 37433344 2023-07-09中科院生物1区top IF=9.8

    (7) Hu C, Zhang X, Hu M, Teng T, Yuan YP, Song P, Kong CY, Xu SC, Ma ZG,Tang QZ. Fibronectin type III domain-containing 5 improves aging-related cardiac dysfunction in mice. Aging Cell. 2022 Mar;21(3):e13556. doi: 10.1111/acel.13556. PMID: 35166002; PMCID: PMC8920441.2022-02-15中科院生物1区top IF=7.8

    (8) Yang D, Liu HQ, Yang Z, Fan D,Tang QZ. BMI1 in the heart: Novel functions beyond tumorigenesis. EBioMedicine. 2021 Jan;63:103193. doi: 10.1016/j.ebiom.2020.103193. Epub 2021 Jan 6. PMID: 33421944; PMCID: PMC7804972. 2021-01-06中科院生物1区top影响因子：11.1

    (9) Hu C, Zhang X, Song P, Yuan YP, Kong CY, Wu HM, Xu SC, Ma ZG,Tang QZ. Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP/PKA/SIRT1 pathway. Redox Biol. 2020 Oct;37:101747. doi: 10.1016/j.redox.2020.101747. Epub 2020 Oct 7. PMID: 33045622; PMCID: PMC7558217 2020-10-07中科院医学1区top影响因子：11.4

    (10) Zhang X, Hu C, Kong CY, Song P, Wu HM, Xu SC, Yuan YP, Deng W, Ma ZG,Tang QZ. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. Cell Death Differ. 2020 Feb;27(2):540-555. doi: 10.1038/s41418-019-0372-z. Epub 2019 Jun 17. PMID: 31209361; PMCID: PMC7206111. 2019-06-17中科院医学1区top影响因子：12.4

    (11) Ma ZG, Kong CY, Wu HM, Song P, Zhang X, Yuan YP, Deng W,Tang QZ. Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice. Theranostics. 2020 Sep 2;10(24):11013-11025. doi: 10.7150/thno.47516. PMID: 33042267; PMCID: PMC7532690. 2019-09-02中科院医学1区top影响因子：12.4

    (12) Hu C, Zhang X, Wei W, Zhang N, Wu H, Ma Z, Li L, Deng W,Tang Q. Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPKα/UCP2 pathway. Acta Pharm Sin B. 2019 Jul;9(4):690-701. doi: 10.1016/j.apsb.2019.03.003. Epub 2019-03-16. PMID: 31384530; PMCID: PMC6664099. 2019-03-16中科院医学1区top影响因子：14.5

    (13) Li N, Zhou H, Wu H, Wu Q, Duan M, Deng W,Tang Q. STING-IRF3 contributes to lipopolysaccharide-induced cardiac dysfunction, inflammation, apoptosis and pyroptosis by activating NLRP3. Redox Biol. 2019 Jun;24:101215. doi: 10.1016/j.redox.2019.101215. Epub 2019 May 13. PMID: 31121492; PMCID: PMC6529775. 2019-05-13中科院医学1区top影响因子：11.4

    (14) Ma ZG, Yuan YP, Zhang X, Xu SC, Kong CY, Song P, Li N,Tang QZ.C1q-tumour necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice. Cardiovasc Res. 2019 May 1;115(6):1067-1077. doi: 10.1093/cvr/cvy279. PMID: 30407523. 2019-05-01中科院医学1区top影响因子：10.8

    (15) Saiyang X, Qingqing W, Man X, Chen L, Min Z, Yun X, Wenke S, Haiming W, Xiaofeng Z, Si C, Haipeng G, Wei D,Qizhu T. Activation of Toll-like receptor 7 provides cardioprotection in septic cardiomyopathy-induced systolic dysfunction. Clin Transl Med. 2021 Jan;11(1):e266. doi: 10.1002/ctm2.266. PMID: 33463061; PMCID: PMC7775988. 2021-01-01中科院医学2区影响因子：10.6

    (16) Hu C, Zhang X, Zhang N, Wei WY, Li LL, Ma ZG,Tang QZ. Osteocrin attenuates inflammation, oxidative stress, apoptosis, and cardiac dysfunction in doxorubicin-induced cardiotoxicity. Clin Transl Med. 2020 Jul;10(3):e124. doi: 10.1002/ctm2.124. Epub 2020 Jul 3. PMID: 32618439; PMCID: PMC7418805. 2020-07-03中科院医学2区影响因子：10.6

    (17) Zhang X, Hu C, Yuan XP, Yuan YP, Song P, Kong CY, Teng T, Hu M, Xu SC, Ma ZG,Tang QZ. Osteocrin, a novel myokine, prevents diabetic cardiomyopathy via restoring proteasomal activity. Cell Death Dis. 2021 Jun 16;12(7):624. doi: 10.1038/s41419-021-03922-2. PMID: 34135313; PMCID: PMC8209005. 2021-06-16中科院医学1区top影响因子：9.0

    (18) Wu QQ, Yao Q, Hu TT, Wan Y, Xie QW, Zhao JH, Yuan Y,Tang QZ. Tax1 banding protein 1 exacerbates heart failure in mice by activating ITCH-P73-BNIP3-mediated cardiomyocyte apoptosis. Acta Pharmacol Sin. 2022 Oct;43(10):2562-2572. doi: 10.1038/s41401-022-00950-2. Epub 2022 Aug 10. PMID: 35948751; PMCID: PMC9525615. 2022-08-10中科院医学1区top影响因子：8.2

    (19) Liao HH, Ding W, Zhang N, Zhou ZY, Ling Z, Li WJ, Chen S,Tang QZ. Activation of AMPKα2 attenuated doxorubicin-induced cardiotoxicity via inhibiting lipid peroxidation associated ferroptosis. Free Radic Biol Med. 2023 Jun 17;205:275-290. doi: 10.1016/j.freeradbiomed.2023.06.004. PMID: 37331642. 2023-06-17中科院医学1区top影响因子：7.4

    (20) Li C, Guo Z, Liu F, An P, Wang M, Yang D,Tang Q. PCSK6 attenuates cardiac dysfunction in doxorubicin-induced cardiotoxicity by regulating autophagy. Free Radic Biol Med. 2023 Jul;203:114-128. doi: 10.1016/j.freeradbiomed.2023.04.005.. PMID: 37061139. 2023-04-13中科院医学1区top影响因子：7.4
    Name Qizhu Tang
    Date of birth Jun, 1963
    Department Department of Cardiology, Renmin Hospital of Wuhan University
    Title The Standing Committee Member of the Wuhan University Party Committee, vice president and medicine minister of Wuhan University, 2nd Class Full Professor, chief physician, doctoral tutor, director of Hubei key Laboratory of Metabolism and Chronic Diseases
    Email qztang@whu.edu.cn
    TEL 13507192218
    Research Direction 1. Myocardial remodeling and cardiovascular disease prevention
    2. Mechanism and prevention of heart failure and cardiomyopathy
    Personal Profile Long-time devotee of cardiovascular diseases prevention and research, presided over more than 10 projects including the National Key Research and Development Program, the National Natural Science Foundation of China Regional Innovation and Development Joint Fund Project, and the National Natural Science Foundation of China Key Project and General Project. Published more than 300 papers in professional journals at home and abroad (including 120 SCI papers), edited 7 monographs, participated in the editing of 12 monographs, presided and completed 2 first prizes of Hubei Province Science and Technology Progress Award, and authorized 2 invention patents, 1 utility model patent and 1 soft. Trained 45 master's students and 31 doctoral students. In the 2012-2022 Elsevier "China Highly Cited Scholars" ranked 9th in cardiovascular.
    Selected Publications (1) Zhang X, Hu C, Ma ZG, Hu M, Yuan XP, Yuan YP, Wang SS, Kong CY, Teng T, Tang QZ. Tisp40 prevents cardiac ischemia/reperfusion injury through the hexosamine biosynthetic pathway in male mice. Nat Commun. 2023 Jun 8;14(1):3383. doi: 10.1038/s41467-023-39159-0. PMID: 37291168; PMCID: PMC10250363. 2023-06-08 Chinese Academy of Sciences Medicine Zone 1 TOP, IF:16.6

    (2) Xie S, Xu SC, Deng W, Tang Q. Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications. Signal Transduct Target Ther. 2023 Mar 14;8(1):114. doi: 10.1038/s41392-023-01378-8. PMID: 36918543; PMCID: PMC10015017. 2023-03-14 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 39.3：

    (3) Xie S, Xing Y, Shi W, Zhang M, Chen M, Fang W, Liu S, Zhang T, Zeng X, Chen S, Wang S, Deng W, Tang Q. Cardiac fibroblast heat shock protein 47 aggravates cardiac fibrosis post myocardial ischemia-reperfusion injury by encouraging ubiquitin specific peptidase 10 dependent Smad4 deubiquitination. Acta Pharm Sin B. 2022 Nov;12(11):4138-4153. doi: 10.1016/j.apsb.2022.07.022. PMID: 36386478; PMCID: PMC9643299. 2022-08-05 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 14.5

    (4) Hu T, Wu Q, Yao Q, Jiang K, Yu J, Tang Q. Short-chain fatty acid metabolism and multiple effects on cardiovascular diseases. Ageing Res Rev. 2022 Nov;81:101706. doi: 10.1016/j.arr.2022.101706. Epub 2022 Aug 4. PMID: 35932976. 2022-08-04 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 13.1

    (5) Xie S, Chen M#, Fang W#, Liu S, Wu Q, Liu C, Xing Y, Shi W, Xu M, Zhang M, Chen S, Zeng X, Wang S, Deng W, Tang Q. Diminished arachidonate 5-lipoxygenase perturbs phase separation and transcriptional response of Runx2 to reverse pathological ventricular remodeling. EBioMedicine. 2022 Dec;86:104359. doi: 10.1016/j.ebiom.2022.104359. PMID: 36395739; PMCID: PMC9672960. 2022-11-14 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 11.1

    (6) Hu T, Wu Q, Yao Q, Yu J, Jiang K, Wan Y, Tang Q. PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy. Metabolism. 2023 Jul 9:155658. doi: 10.1016/j.metabol.2023.155658. Epub ahead of print. PMID: 37433344 2023-07-09 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 9.8

    (7) Hu C, Zhang X, Hu M, Teng T, Yuan YP, Song P, Kong CY, Xu SC, Ma ZG, Tang QZ. Fibronectin type III domain-containing 5 improves aging-related cardiac dysfunction in mice. Aging Cell. 2022 Mar;21(3):e13556. doi: 10.1111/acel.13556. PMID: 35166002; PMCID: PMC8920441.2022-02-15 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 7.8

    (8) Yang D, Liu HQ, Yang Z, Fan D, Tang QZ. BMI1 in the heart: Novel functions beyond tumorigenesis. EBioMedicine. 2021 Jan;63:103193. doi: 10.1016/j.ebiom.2020.103193. Epub 2021 Jan 6. PMID: 33421944; PMCID: PMC7804972. 2021-01-06 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 11.1

    (9) Hu C, Zhang X, Song P, Yuan YP, Kong CY, Wu HM, Xu SC, Ma ZG, Tang QZ. Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP/PKA/SIRT1 pathway. Redox Biol. 2020 Oct;37:101747. doi: 10.1016/j.redox.2020.101747. Epub 2020 Oct 7. PMID: 33045622; PMCID: PMC7558217 2020-10-07 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 11.4

    (10) Zhang X, Hu C, Kong CY, Song P, Wu HM, Xu SC, Yuan YP, Deng W, Ma ZG, Tang QZ. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. Cell Death Differ. 2020 Feb;27(2):540-555. doi: 10.1038/s41418-019-0372-z. Epub 2019 Jun 17. PMID: 31209361; PMCID: PMC7206111. 2019-06-17 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 12.4

    (11) Ma ZG, Kong CY, Wu HM, Song P, Zhang X, Yuan YP, Deng W, Tang QZ. Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice. Theranostics. 2020 Sep 2;10(24):11013-11025. doi: 10.7150/thno.47516. PMID: 33042267; PMCID: PMC7532690. 2019-09-02 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 12.4

    (12) Hu C, Zhang X, Wei W, Zhang N, Wu H, Ma Z, Li L, Deng W, Tang Q. Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPKα/UCP2 pathway. Acta Pharm Sin B. 2019 Jul;9(4):690-701. doi: 10.1016/j.apsb.2019.03.003. Epub 2019-03-16. PMID: 31384530; PMCID: PMC6664099. 2019-03-16 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 14.5

    (13) Li N, Zhou H, Wu H, Wu Q, Duan M, Deng W, Tang Q. STING-IRF3 contributes to lipopolysaccharide-induced cardiac dysfunction, inflammation, apoptosis and pyroptosis by activating NLRP3. Redox Biol. 2019 Jun;24:101215. doi: 10.1016/j.redox.2019.101215. Epub 2019 May 13. PMID: 31121492; PMCID: PMC6529775. 2019-05-13 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 11.4

    (14) Ma ZG, Yuan YP, Zhang X, Xu SC, Kong CY, Song P, Li N, Tang QZ. C1q-tumour necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice. Cardiovasc Res. 2019 May 1;115(6):1067-1077. doi: 10.1093/cvr/cvy279. PMID: 30407523. 2019-05-01 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 10.8

    (15) Saiyang X, Qingqing W, Man X, Chen L, Min Z, Yun X, Wenke S, Haiming W, Xiaofeng Z, Si C, Haipeng G, Wei D, Qizhu T. Activation of Toll-like receptor 7 provides cardioprotection in septic cardiomyopathy-induced systolic dysfunction. Clin Transl Med. 2021 Jan;11(1):e266. doi: 10.1002/ctm2.266. PMID: 33463061; PMCID: PMC7775988. 2021-01-01 Chinese Academy of Sciences Medicine Zone 2, IF: 10.6

    (16) Hu C, Zhang X, Zhang N, Wei WY, Li LL, Ma ZG, Tang QZ. Osteocrin attenuates inflammation, oxidative stress, apoptosis, and cardiac dysfunction in doxorubicin-induced cardiotoxicity. Clin Transl Med. 2020 Jul;10(3):e124. doi: 10.1002/ctm2.124. Epub 2020 Jul 3. PMID: 32618439; PMCID: PMC7418805. 2020-07-03 Chinese Academy of Sciences Medicine Zone 2, IF: 10.6

    (17) Zhang X, Hu C, Yuan XP, Yuan YP, Song P, Kong CY, Teng T, Hu M, Xu SC, Ma ZG, Tang QZ. Osteocrin, a novel myokine, prevents diabetic cardiomyopathy via restoring proteasomal activity. Cell Death Dis. 2021 Jun 16;12(7):624. doi: 10.1038/s41419-021-03922-2. PMID: 34135313; PMCID: PMC8209005. 2021-06-16 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 9.0

    (18) Wu QQ, Yao Q, Hu TT, Wan Y, Xie QW, Zhao JH, Yuan Y, Tang QZ. Tax1 banding protein 1 exacerbates heart failure in mice by activating ITCH-P73-BNIP3-mediated cardiomyocyte apoptosis. Acta Pharmacol Sin. 2022 Oct;43(10):2562-2572. doi: 10.1038/s41401-022-00950-2. Epub 2022 Aug 10. PMID: 35948751; PMCID: PMC9525615. 2022-08-10 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 8.2

    (19) Liao HH, Ding W, Zhang N, Zhou ZY, Ling Z, Li WJ, Chen S, Tang QZ. Activation of AMPKα2 attenuated doxorubicin-induced cardiotoxicity via inhibiting lipid peroxidation associated ferroptosis. Free Radic Biol Med. 2023 Jun 17;205:275-290. doi: 10.1016/j.freeradbiomed.2023.06.004. PMID: 37331642. 2023-06-17 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 7.4

    (20) Li C, Guo Z, Liu F, An P, Wang M, Yang D, Tang Q. PCSK6 attenuates cardiac dysfunction in doxorubicin-induced cardiotoxicity by regulating autophagy. Free Radic Biol Med. 2023 Jul;203:114-128. doi: 10.1016/j.freeradbiomed.2023.04.005.. PMID: 37061139. 2023-04-13 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 7.4



    友情链接：湖北省人民政府武汉大学国家卫生健康委员会湖北省卫生健康委员会中华人民共和国教育部中华人民共和国科技部武汉市卫生健康委员会
    武汉大学人民医院 湖北省人民医院
    湖北省人民医院 武汉大学人民医院

    医院概况 | English | Francaise | 站点地图

    医院地址：湖北武汉武昌区张之洞路99号解放路238号 邮编：430060 邮箱：whdxrmyy&126.com

    Copyrights©2002-2020 All Rights Reserved. 武汉大学人民医院 湖北省人民医院 版权所有

    鄂ICP备：19028677号 鄂公网安备：42010602002990号 如有转载或引用本站文章涉及版权问题，请与我们联系